Global /Singapore /Healthcare /Diagnostics & Research /1H3
chevron_leftBack
C

Clearbridge Health Ltd.

1H3
SGX: 1H3 Delayed
0.0030SGD 0%
0.0023 USD
As of 24 April 2025, Clearbridge Health Ltd. has a market cap of $4.94M USD, ranking #35601 globally and #550 in Singapore. It ranks #3585 in the Healthcare sector, and #187 in the Diagnostics & Research industry.
Global Rank
35601
Country Rank
550
Sector Rank
3585
Industry Rank
187
Key Stats
Market Cap
$4.94MUSD
6.51M SGD
Enterprise Value
$7.37MUSD
9.69M SGD
Revenue (TTM)
$7.53MUSD
9.9M SGD
EBITDA (TTM)
-$2.79MUSD
-3.67M SGD
Net Income (TTM)
-$2.74MUSD
-3.61M SGD
EBITDA Margin
-37%
Profit Margin
-36%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Pinh Yee open_in_new
Employees
121
Founded
2010
Website
clearbridgehealth.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% 50% 0% -63% -70%

Markets

Exchange Ticker Price
Singapore Exchange
MIC: XSES
PRIMARY
1H3
Clearbridge Health Ltd
ISIN: SG1EB6000000
Shares Out.:
2.169B1 Shares Float: 1.271B2
TV:
SA:
YF:
GF:
BA:
1H3
MS:
0.0030 SGD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Clearbridge Health Ltd.

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.

Similar Companies

Industry: Diagnostics & Research (Singapore)
Name
Market Cap diff.
H
HC Surgical Specialists Ltd.
1B1
$31.47M
41.41M SGD
536%
Cordlife Group Ltd.
P8A
$29.41M
38.7M SGD
495%
B
Biolidics Ltd.
8YY
$26.99M
35.51M SGD
446%
A
AsiaMedic Ltd.
505
$8.77M
11.55M SGD
77%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
3M%
Danaher Corp.
DHR
$140.45B
3M%
Lonza Group AG
LONN
$46.75B
38.79B CHF
945K%
IDEXX Laboratories, Inc.
IDXX
$34.63B
700K%
Agilent Technologies, Inc.
A
$29.94B
605K%